ELISA kit for Human Zika Virus IgG (ZV-IgG) |
KTE62724-48T |
Abbkine |
48T |
EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human Zika Virus IgG (ZV-IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Human IgG antibody Laboratories manufactures the large antibody study offers for virus reagents distributed by Genprice. The Large Antibody Study Offers For Virus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Large products are available in stock. Specificity: Large Category: Antibody Group: Study Offers
ELISA kit for Human epstein-barr virus (EBv)antibody (IgG) |
SAB |
96 tests |
EUR 996 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human epstein-barr virus (EBv)antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Human hepatitis D virus (HDV) antibody (IgG) |
SAB |
96 tests |
EUR 854.4 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human hepatitis D virus (HDV) antibody (IgG) in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) |
Abbkine |
48T |
EUR 398.4 |
|
Description: Quantitative sandwich ELISA for measuring Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
Description: Quantitative sandwich ELISA for measuring Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) |
Abbkine |
96T |
EUR 646.8 |
|
Description: Quantitative sandwich ELISA for measuring Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA Kit for IgG Antibody to Hepatitis E Virus |
Biochain |
1 kit |
EUR 247 |
ELISA kit for Human Hepatitis A Virus IgG (HAV IgG) |
Abbkine |
48T |
EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human Hepatitis A Virus IgG (HAV IgG) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Study Offers information
Hepatitis B virus genotype C subtype adr Large envelope protein (S) |
1-CSB-YP335673HEC |
Cusabio |
-
EUR 814.80
-
EUR 402.00
-
EUR 2606.40
-
EUR 1261.20
-
EUR 1730.40
-
EUR 522.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Hepatitis B virus genotype C subtype adr Large envelope protein(S),partial expressed in Yeast |
Perlecan Antibody (Large) |
V2600-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Perlecan Antibody (Large) |
V2600-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Perlecan Antibody (Large) |
V2600IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Perlecan Antibody (Large) |
V2600SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Perlecan Antibody (Large) |
V2601-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Perlecan Antibody (Large) |
V2601-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Perlecan Antibody (Large) |
V2601IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Perlecan Antibody (Large) |
V2601SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment. |
Large T Antigen (LT) Antibody |
20-abx177313 |
Abbexa |
|
|
|
Mouse antibody for BK virus VP1 |
4942 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against BK virus VP1 for WB, ELISA. |
Mouse antibody for BK virus VP1 |
4943 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against BK virus VP1 for WB, ELISA. |
Mouse antibody for Rabies virus |
6041 |
Virostat |
100 ug |
EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against Rabies virus for WB, ELISA. |
Like Glycosyltransferase (LARGE) Antibody |
abx234697-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
Like Glycosyltransferase (LARGE) Antibody |
20-abx128114 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1446.00
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Like Glycosyltransferase (LARGE) Antibody |
20-abx124463 |
Abbexa |
|
|
|
Like Glycosyltransferase (LARGE) Antibody |
abx432911-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|